Upgrades

Biocon’s Q2FY26 revenue growth of 19.6% YoY was driven by recent launches like bUstekinumab, bAspart, bBevacizumab and bAflibercept, and the launch of generic liraglutide.

due to adverse commodity prices, unfavorable foreign exchange movement, higher *over or under performance to benchmark index to 11.0% during the quarter. EBITDA margin contracted due to increased cost of...

Samvardhana Motherson (SAMIL) delivered a largely in-line performance, with consol revenue up 8.5% YoY (6% ex-Atsumitech) to Rs301.7bn, with EBITDAM at 8.7% (vs 8.8% YoY), while APAT at Rs7.3bn was modestly below expectations.

We maintain Buy on JUBI with unchanged TP of Rs825 (34x Sep-27 EBITDA), on assuring management commentary around delivering mid-teen topline growth along with gradual margin gains – both have been key investor concerns in our view.

Eicher's 2QFY26 consolidated PAT at INR13.6b was slightly lower than our estimates of INR14.4b, due to lower-than-expected margins in both segments.

Lemon Tree Hotels Ltd.'s (LTH) Q2FY26 result was in-line with our estimates on key parameters. The hospitality industry witnessed multiple headwinds during H1FY26 including geopolitical tensions, floods, tariff wars, and GST revisions, which led to muted demand in Q2. Despite these challenges, LTH reported the best ever Q2 performance. Management noted that demand continues to outpace supply, especially in Tier 2 and Tier 3 markets where branded inventory remains limited and pricing power is improving. Room rates across the industry are still about 20% lower than 200708 levels (inflation-adjusted), indicating...

Tata Steel's Q2FY26 performance was above our expectations. Revenue increased 10% QoQ to Rs586bn, driven by 11% increase in volumes, aided by strong growth in India operations. However, this was partially offset by a 1% QoQ decrease in realizations owing to weak steel prices. Consolidated EBITDA increased 20% QoQ to Rs89bn, with EBITDA/t improving 8% QoQ to Rs11,247. UK operations saw EBITDA loss widen to Rs13,510/t in Q2FY26 from Rs7,829/t in Q1FY26, while the Netherland business posted improved EBITDA of Rs5,948/t, up from Rs4,074/t in Q1FY26. The improvement was supported by global cost...

Century Plyboards' Q2FY26 performance was above expectations. Revenue grew 17% YoY to Rs14bn, driven by strong growth in MDF (+28% YoY), Plywood (+15% YoY), and Laminate (+17% YoY), despite a decline in Particle boards (-18% YoY). EBITDA margin expanded by 320bps YoY to 12.6%, supported by margin improvement across MDF and laminates segment. Additionally, the new plywood facility at Hoshiarpur (capacity: 50,000 CBM), commenced operations, taking its plywood capacity to 3,94,800 CBM. Further, new plywood capacity expansion at Puttur has been initiated and is expected to commence operations...

We recommend the BUY rating.